Profile | GDS4284 / 208732_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1359.39 | 78 |
GSM687648 | Patient 402 control | 1692.41 | 81 |
GSM687653 | Patient 403 control | 2057.27 | 84 |
GSM687658 | Patient 404 control | 1659.61 | 81 |
GSM687663 | Patient 411 control | 1702.58 | 82 |
GSM687668 | Patient 422 control | 1794.68 | 82 |
GSM687673 | Patient 424 control | 1543.47 | 80 |
GSM687678 | Patient 425 control | 1537.93 | 80 |
GSM687683 | Patient 427 control | 1525.1 | 80 |
GSM687688 | Patient 428 control | 1872.96 | 83 |
GSM687695 | Patient 441 control | 2417.92 | 87 |
GSM687699 | Patient 443 control | 1939.21 | 84 |
GSM687704 | Patient 444 control | 1631.56 | 81 |
GSM687707 | Patient 448 control | 1519.03 | 80 |
GSM687712 | Patient 449 control | 1494.3 | 80 |
GSM687719 | Patient 450 control | 1550.18 | 80 |
GSM687724 | Patient 451 control | 1738.29 | 82 |
GSM687728 | Patient 452 control | 1880.1 | 83 |
GSM687646 | Patient 401 treated 24h | 1219.1 | 77 |
GSM687649 | Patient 402 treated 24h | 1649.6 | 81 |
GSM687665 | Patient 411 treated 24h | 1914.14 | 83 |
GSM687651 | Patient 402 treated 4 weeks | 1586.89 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 2046.1 | 84 |
GSM687670 | Patient 422 treated 24h | 1729.32 | 82 |
GSM687671 | Patient 422 treated 4 weeks | 1300.68 | 77 |
GSM687654 | Patient 403 treated 24h | 1996.69 | 84 |
GSM687675 | Patient 424 treated 24h | 1393.96 | 79 |
GSM687685 | Patient 427 treated 24h | 1624.17 | 81 |
GSM687656 | Patient 403 treated 4 weeks | 1902.63 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 1441.75 | 79 |
GSM687687 | Patient 427 treated 4 weeks | 1599.28 | 80 |
GSM687692 | Patient 428 treated 4h | 1837.49 | 83 |
GSM687716 | Patient 449 treated 4h | 1265.43 | 78 |
GSM687722 | Patient 450 treated 4h | 1826.05 | 83 |
GSM687680 | Patient 425 treated 24h | 2069.11 | 84 |
GSM687690 | Patient 428 treated 24h | 2263.5 | 86 |
GSM687700 | Patient 443 treated 24h | 2015.75 | 84 |
GSM687705 | Patient 444 treated 24h | 1431.11 | 79 |
GSM687714 | Patient 449 treated 24h | 1444.69 | 80 |
GSM687721 | Patient 450 treated 24h | 1780.19 | 83 |
GSM687682 | Patient 425 treated 4 weeks | 1980.42 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 1906.72 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1940.59 | 84 |
GSM687718 | Patient 449 treated 4 weeks | 1101.28 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 1656.41 | 81 |
GSM687661 | Patient 404 treated 4h | 1812.79 | 82 |
GSM687710 | Patient 448 treated 4h | 1507.4 | 80 |
GSM687726 | Patient 451 treated 4h | 1966.73 | 84 |
GSM687730 | Patient 452 treated 4h | 1404.58 | 80 |
GSM687660 | Patient 404 treated 24h | 2560.9 | 88 |
GSM687697 | Patient 441 treated 24h | 2158.05 | 86 |
GSM687709 | Patient 448 treated 24h | 1683.98 | 82 |
GSM687725 | Patient 451 treated 24h | 1820.9 | 83 |
GSM687729 | Patient 452 treated 24h | 2690.9 | 88 |
GSM687727 | Patient 451 treated 4 weeks | 1783.39 | 82 |
GSM687731 | Patient 452 treated 4 weeks | 2081.14 | 84 |